Item 8.01 Other Events On July 9, 2026, the Board of Directors of Neuraxis, Inc. (the “ Company ”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “ Series B Preferred Stock ”) for the second quarter of 2026 (the “ Second Quarter Dividend ”).…
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events
On
July 9, 2026, the Board of Directors of Neuraxis, Inc. (the “ Company ”) authorized and the Company declared a stock
dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “ Series B Preferred Stock ”)
for the second quarter of 2026 (the “ Second Quarter Dividend ”). The Second Quarter Dividend will be paid in the
form of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The number of shares
of Common Stock to be received by each holder will be determined based on the accrued and unpaid dividends on such holder’s Series
B Preferred Stock from April 1, 2026 through the record date, divided by $2.38. A total of approximately 80,463 shares of Common Stock
are expected to be issued in connection with the Second Quarter Dividend. No fractional shares will be issued in connection with the
Second Quarter Dividend. In lieu of any fractional shares, holders of Series B Preferred Stock who would otherwise be entitled to receive
a fractional share of Common Stock will receive cash (without interest or deduction) in an amount equal to the product obtained by multiplying
(a) $2.38 by (b) the fraction of one share of Series B Preferred Stock owned by such holder. The Second Quarter Dividend will be
payable on July 29, 2026, to holders of record of the Company’s Series B Preferred Stock as of the close of business on
July 21, 2026.